BOZEN, Sud-Tirol, Italy, April 3, 2013 /PRNewswire/ --
Health Robotics today announced the already scheduled Pharmacy Symposium demonstrations [including private demos] of its world-leading Robots and IV Workflow solutions at the Amerinet 2013 Member Conference to be held May 19-22 in Orlando [FL]; the American Society of Health-System Pharmacists 2013 Summer Meeting to be organized June 1-5 in Minneapolis [MN]; and the Premier 2013 Breakthroughs Conference to be held June 11-14 in San Antonio [TX].
Interested Health-System pharmacy personnel are able to consult the scheduled demonstration events by viewing http://www.health-robotics.com/en/about-health-robotics/events/, and may pre-arrange private visits to Health Robotics' Booths by promptly contacting Claudia Perez at: email@example.com.
Gaspar DeViedma, Health Robotics' Executive Vice President and Board Member, stated: "These are great opportunities for Health-System pharmacy staff to see live demonstrations of our award winning solutions and privately interact with Health Robotics' USA-based leadership, management, and engineering staff. During 1Q2013, USA-based Health-System pharmacists continued to overwhelmingly recognize the undeniable fact that Health Robotics' second generation modular architecture of integrated and networked medical devices are fully automated, offer 3 to 4 times faster speed/throughput, for less than half the price, size, and weight than any of its global competitors, while delivering payback periods/R.O.I. of less than 1 year. This has been by far the best 1Q for Health Robotics in the USA."
Only Amerinet and Premier members may respectively attend the Orlando and San Antonio events, directly as a result of exclusive agreements with Health Robotics. Amerinet singularly awarded Health Robotics with a sole source contract in March 2013 for i.v.STATION, i.v.STATION ONCO, and i.v.SOFT, http://www.health-robotics.com/smartedit/downloads/en/hr-amerinet-final.pdf, while Premier issued an exclusive award to Health Robotics' for i.v.STATION and i.v.STATION ONCO in 2012, http://www.health-robotics.com/smartedit/downloads/en/premierpr.pdf.
About Health Robotics:
Founded in 2006 and now reaching 80% total IV Robots market share in the world [including over 90% the Oncology Robots global market], Health Robotics is the undisputed leading supplier of life-critical intravenous medication robots, providing over 300 hospital installations in 5 continents with the only fully-integrated robotics-based technology, IV Workflow, and manual compounding software automation solution. Health Robotics' second generation solutions [i.v.STATION, i.v.SOFT, and i.v.STATION ONCO] have been found [through scientific and peer-reviewed studies1,2] to greatly contribute to ease hospitals' growing pressures to improve patient safety, increase throughput, and contain costs1. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' medical devices and integrated workflow solutions help hospitals eliminate life-threatening drug1 and diluent1 exchange errors, improve drug potency, decrease other medical mistakes and sterility risks, work more efficiently1, reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce nursing, and pharmacy staff. For more information, please visit: http://www.health-robotics.com
1. Impact of Robotic Antineoplastic Preparation on Safety, Workflow, Costs. Seger, Churchill, Keohane, Belisle, Wong, Sylvester, Chesnick, Burdick, Wien, Cotugno, Bates, and Rothschild. Brigham & Women's Hospital, Massachusetts College of Pharmacy, and Harvard Medical School. Journal of Oncology Practice, Nov. 2012, Volume 8, number 6.
2. Validation of an automated method for compounding monoclonal antibody patient doses: case studies of Avastin®, Remicade®, and Herceptin®. Peters, Capelle, Arvinte, van de Garde. St. Antonius Hospital. mAbs January 2013, Volume 5, Issue 1.
For additional information, please contact:
SOURCE Health Robotics